Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial

Affiliations

• ¹ Centre for Human Drug Research, Leiden, The Netherlands; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
• ² Centre for Human Drug Research, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands.
• ³ Centre for Human Drug Research, Leiden, The Netherlands; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
• ⁴ Centre for Human Drug Research, Leiden, The Netherlands.
• ⁵ Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
• ⁶ Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
• ⁷ Centre for Human Drug Research, Leiden, The Netherlands; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands. Electronic address: rrissmann@chdr.nl.